Fiche centre
Luoyang Central Hospital
Luoyang — China
Essais liés7clinical trials
VilleLuoyanglocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07220538
Essais cliniques associés
7| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Albumin | Accident vasculaire cérébral | Phase 3 | NCT07263308 | ARISE-2 — Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2 | RECRUITING |
| BI 690517 | Maladie rénale chronique | Phase 3 | NCT06531824 | EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) | ACTIVE_NOT_RECRUITING |
| Tocilizumab | Accident vasculaire cérébral | Phase 3 | NCT07509645 | IRIS-3 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke | RECRUITING |
| Tenecteplase | Accident vasculaire cérébral | Phase 3 | NCT07361302 | TENACITY — A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well | RECRUITING |
| Extract of Ginkgo Biloba Leaves Tablets 240 mg (2 x 40 mg, t.i.d.) | Accident vasculaire cérébral | Phase 4 | NCT07220538 | GiCIIS — A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment | ACTIVE_NOT_RECRUITING |
| SG301 SC Injection | Lupus | Phase 2 | NCT07447986 | To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus | RECRUITING |
| Yangxue Qingnao Granules (Pills) | Migraine | À vérifier | NCT05334927 | CHAIRS — China HeadAche DIsorders RegiStry | RECRUITING |